ArticleMethods in molecular biology (Clifton, N.J.)2025
Coupling Affinity Purification with Proximity Labeling in Arabidopsis: The APEAL Approach.
Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Capturing interactions in transient protein assemblies is a challenging task. We introduce an approach named APEAL (Tandemly Coupled Affinity Purification with Proximity-dEpendent LigAtion) for determining both transient and stable protein assemblies in Arabidopsis and other plants. APEAL exploits TurboID, a biotin ligase variant that operates efficiently at "plant-friendly" temperatures. The APEAL method begins by enriching strong or long-lived protein-protein interactions through an affinity purification step. It then captures weaker and more transient interactions through a proximity-dependent ligation step. At both stages, samples can be analyzed using immunoblotting or mass spectrometry to extract relevant data. This chapter details the APEAL procedure from construct design and pilot experiments to condition testing, proteomic sample collection, and mass spectrometry data analyses.
Indexed as
Identifiers
40638047What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.